Search

Search Results
Results 91 - 100 of 2346 for Targeted drug delivery
  • Supplier Profile
    Nanostructured & Amorphous Materials Inc. (NanoAmor) was founded in Los Alamos, New Mexico, USA, in September 2001. NanoAmor is a leading nanomaterials company, involved in all aspects of the...
  • Supplier Profile
    CPI is the driving force behind a number of the North East's strategic R&D initiatives. Each of CPI' programmes focuses on bringing cutting edge technology research to the region, which...
  • Supplier Profile
    Accelrys® (NASDAQ:ACCL) has over twenty years of leadership in the delivery of computational science and informatics software to diverse R&D organizations. The company combines experience and...
  • Supplier Profile
    The Birck Nanotechnology Center opened in July of 2005. This $58 million facility comprises 187,000 square feet, providing office space for 45 faculty, 21 clerical and technical staff, and up to 180...
  • Article - 1 Aug 2005
    Nanotechnology enhances disease detection and drug delivery using biolabels like dendrimers and magnetic nanoparticles for early diagnosis and targeted therapy.
  • Article - 26 Jul 2005
    Nanotechnology is set to play an important role in the pharmaceutical and healthcare sectors for humans and animals. How nanoparticles, microfluidic devices, biochips, nanoshells, nanocapsules,...
  • Article - 9 Feb 2022
    To advance nanomedicine, researchers will need to overcome the barrier that prevents clinical applications of nanomaterial systems.
  • Article - 12 Apr 2005
    Specially prepared crystalline semiconductors that emit different colours of light when illuminated by lasers allow scientists to watch the inner workings of a living cell. The process consists of...
  • Article - 17 Jan 2005
    Using external laser light to open gold-coated nanocapsules could lead to controlled and intelligent delivery of drugs and other substances. Researchers working on drug delivery systems have...
  • Video
    Magnetic-materials specialist Kevin O'Grady predicts a big future for magnetic nanoparticles in clinical applications ranging from targeted drug delivery to the heat treatment of cancerous tumours.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.